Gadoterate meglumine
Drug ingredientCAS 92943-93-6
This chemical is an active pharmaceutical ingredient used in FDA-regulated drugs.
US productionNot reported
Top sourceNo public record
This chemical is not on EPA’s Toxic Substances Control Act inventory, the list behind EPA’s production survey.
Why supply is unknownWhere It Comes From
EPA and Census publish no US supply data for this chemical.
7 FDA-registered drug labelers
Formosa Laboratories, Inc.
Fresenius Kabi USA, LLC
GE Healthcare
Guerbet LLC
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
SIONC PHARMACEUTICALS PVT LTD
Slate Run Pharmaceuticals, LLC
Why It Matters
Sectors
Health
Downstream Uses
Appears in 3 drug and cosmetic product listings (FDA).
- •Dotarem
- •Gadoterate Meglumine
- •Clariscan
FDA Shortage Status
Whether any manufacturer currently reports this drug as in shortage on the FDA Drug Shortages database. "Active Shortage" means at least one presentation has status "current."
No FDA shortage records
Chemical Identity
CAS92943-93-6
PubChem CID6918037
DTXSIDDTXSID80918856
FormulaC23H42GdN5O13
Mol. Weight753.9 g/mol
SMILESCNCC(C(C(C(CO)O)O)O)O.C1CN(CCN(CCN(CCN1CC(=O)O)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].[Gd+3]
Data Sources
- PubChem · compound 6918037Retrieved 2026-04-07
- FDA National Drug Code directoryRetrieved 2026-04-25
- FDA National Drug Code directoryRetrieved 2026-04-07
Brief citations
Gadoterate meglumine (CAS 92943-93-6) https://chemicalindependence.com/chemical/92943-93-6/ PubChem: 6918037. Retrieved 2026-04-07. https://pubchem.ncbi.nlm.nih.gov/compound/6918037 FDA National Drug Code directory: CAS 92943-93-6. Retrieved 2026-04-25. https://open.fda.gov/data/ndc/ FDA National Drug Code directory: bulk match. Retrieved 2026-04-07. https://open.fda.gov/data/ndc/